Sign in
ACST Stock Price, Chart, Stats & News
Acasti Pharma Inc.
Save
34.17M
Market cap
–
Current P/E
–
Forward P/E
ACST chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 0.02% |
Operating margin | 202.65% |
Pretax margin | -144.78% |
Net margin | -177.38% |
Effective tax rate | -22.52% |
ROA | -12.52% |
ROE | -13.30% |
D/E | – |
Interest coverage ratio | 41.68x |
ACST valuation
P/E | – |
P/S | 7.07x |
P/B | 0.88x |
P/CF | -7.09x |
P/FCF | -4.23x |
P/OCF | -7.09x |
PEG | -0.16x |
EV multiple | -85.23x |
About
Acasti Pharma Inc. operates as a biopharmaceutical firm, concentrating its efforts on developing and marketing pharmaceutical solutions specifically for cardiovascular conditions. The company is currently exploring potential strategic alliances to further the clinical development of its drug candidate, CaPre. This Canadian company, which was established in 2002, has its main offices located in Laval.
Similar securities
Based on sector and market capitalization
Report issue